Sanofi : FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma

NEXT STORY
BC researchers secure $10M in funding to examine the effectiveness of genomics in clinical health care
PREV STORY
Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

First Fertility Partners With The Fertility Institute of New Orleans

author_avatar
NASDAQ Market News

Oncology Venture – First day of trading in investor warrants

author_avatar
NASDAQ Market News

ADMA Biologics Receives Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA

RAMSEY, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage ...

author_avatar
NASDAQ Market News